Virtus Fund Advisers’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,900	Closed	-$21.8K	–	107
2022 Q4	$21.8K	Buy	+1,900	New	+$21.8K	0.16%	96
2017 Q4	$349K	Buy	+71,081	New	+$349K	﹤0.01%	404
2014 Q3	–	Sell	-5,979	Closed	-$76K	–	1235
2014 Q2	$76K	Buy	+5,979	New	+$76K	﹤0.01%	1583